Weak Association Between Genetic Markers of Hyperuricemia and Cardiorenal Outcomes: Insights From the STANISLAS Study Cohort With a 20-Year Follow-Up
To assess the G/D-CuPs biocompatibility and its ability to support cell growth, we performed in vitro three-dimensional (3D) culture experiments using NIH/3T3 cells as a model
Originally developed to treat type 2 diabetes, these drugs are now helping many people lose significant amounts of weight
In vitro studies by Wang et al., using HUVEC cells, suggest that GHK-Cu may stimulate the expression of vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2), both of which are well-characterized mediators of endothelial cell proliferation and new vessel formation
Musculoskeletal Research: BPC-157 is evaluated in animal models of tendon, ligament, skeletal muscle, and bone repair
Most physicians prefer the well-studied CJC-1295/Ipamorelin combination when a dual-pathway approach is warranted